Skip to main content
TipRanks
Go Ultimate75% OFF

THG (HG0) AI Stock Analysis

6 Followers
DE:HG0

THG

(Frankfurt:HG0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue and EBITDA recoveryThe return to meaningful revenue growth alongside sharply higher adjusted EBITDA indicates improving commercial traction and operating leverage. If sustained, this recovery can strengthen earnings capacity, support reinvestment in core brands, and improve the durability of cash generation over the next several quarters.
Negative Factors
Weak recent cash conversionNegative operating and free cash flow means recent accounting improvement has not yet translated into dependable cash generation. This can increase funding needs, constrain investment flexibility, and make the recovery more vulnerable if profitability or working-capital performance weakens.

THG (HG0) vs. iShares MSCI Germany ETF (EWG)

-50%-40%-30%-20%-10%0%10%20%DE:HG0-10.29%EWG+6.38%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 607.77M
Dividend Yield
―
Average Volume (3M)
1,050
Price to Earnings (P/E)
-9.5
Beta (1Y)
1.45
Revenue Growth
6.50%
EPS Growth
59.15%
Country
Germany
Employees
2,670
Sector
Consumer Cyclical
Sector Strength
61
Industry
Specialty Retail

THG Business Overview & Revenue Model

Company Description

THG Plc operates as an online retailer in the United Kingdom, the United States, Europe, and internationally. It operates through the THG Beauty and THG Nutrition segments. The THG Beauty segment manufactures and retails skincare, haircare, cosmetics...

THG Earnings Call Summary

Earnings Call Date:Sep 10, 2026(Q2-2026)|% Change Since:29.00%|Next Earnings Date:Apr 15, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Highlights significantly outweighed the lowlights, with 7.2% revenue growth, adjusted EBITDA of £42.8 million, improved free cash flow, strong Myprotein volume growth, Beauty market-share gains, and a constructive outlook. The main challenges were whey-cost inflation, the delayed VAT claim update, U.S. manufacturing dispatch delays and some trading softness related to EU duties and sales phasing.

Positive Updates

Strong First-Half Revenue and Profitability Growth
Group revenue increased by 7.2% to £829 million in H1 26. Adjusted EBITDA reached £42.8 million, more than double the prior year when adjusting for the disposal of Claremont Ingredients.

Negative Updates

Significant Whey Protein Cost Inflation
Since 2021, whey protein costs have increased approximately 5-fold. Management said this creates pressure for both consumers and industry margins, although it also reported solid margin progression during H1.

Company Guidance

For the full year, THG expects 25% to 35% of positive free cash flow, with £25 million to £35 million of positive free cash flow, while continuing to grow market share and progress margins; for Q3, it expects constant currency sales growth of approximately 2% with earnings and cash remaining robust, after approximately 5% revenue growth achieved in July and August, and for Q4, it expects revenue growth to accelerate to approximately 6% to 7%. Myprotein remains on track to sell approximately 130 million branded units for the full year of 2026, following 58.5 million units sold in H1, and the group expects to sell over 250 thousand advent calendar units this year. The combination of EBITDA growth and improving cash flow through 2026 and 2027, together with the conclusion and receipt of the HMRC VAT claim, should see group net debt reduced to approximately 1x leverage for full year 2027; if any meaningful transaction materialise over the year ahead, the group would move into a net cash positive position by the end of full year 2027. THG remains confident in baseline divisional EBITDA margins of more than 6% for THG Beauty and more than 12% for THG Nutrition, with increasing confidence in the trajectory towards its targeted 12% EBITDA margin.

THG Risk Analysis

THG disclosed 12 risk factors in its most recent earnings report. THG reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

THG Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:HG0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:FRASGB:FRAS78OutperformGBP 4.14B11.1015.67%―8.13%28.46%
GB:CURYGB:CURY71OutperformGBP 1.47B9.287.10%2.09%6.29%55.06%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
GB:ASCGB:ASC59NeutralGBP 523.86M11.37-155.17%―-9.11%―
GB:JDGB:JD55NeutralGBP 4.59B8.2718.67%1.34%2.06%14.07%
GB:DEBSGB:DEBS48NeutralGBP 395.37M-5.37183.74%―120.30%66.52%

* Consumer Cyclical Sector Average

Performance Comparison

0%50%100%DE:HG0GB:ASCGB:FRASGB:DEBSGB:CURYGB:JDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:HG0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:HG0Thg Plc0.43-0.05-10.29%
GB:ASCASOS plc466.00203.0077.19%
GB:FRASFrasers Group Plc953.00243.0034.23%
GB:DEBSboohoo group Plc26.0012.8096.97%
GB:CURYCurrys Plc143.7015.8312.38%
GB:JDJD Sports Fashion94.6611.7914.23%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.